Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2017-05-20 2017-05-19
Drug Identification Number 02290308 02290308
Brand name CYESTRA-35 CYESTRA-35
Common or Proper name Ethinyl Estradiol Cyproterone Acetate Ethinyl Estradiol Cyproterone Acetate
Company Name PALADIN LABS INC. PALADIN LABS INC.
Ingredients ETHINYL ESTRADIOL CYPROTERONE ACETATE ETHINYL ESTRADIOL CYPROTERONE ACETATE
Strength(s) 0.035MG 2MG 0.035MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 21 Tablets 21 Tablets
ATC code G03HB G03HB
ATC description ANTIANDROGENS ANTIANDROGENS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-04-13 2017-04-13
Actual start date 2017-04-13 2017-04-13
Estimated end date 2017-05-23 2017-05-23
Actual end date 2017-05-19 2017-05-19
Shortage status Resolved Actual shortage
Company comments
Health Canada comments